Mar 242011
Brassard et al analyzed a Canadian database cohort of >427,000 people and, finding 564 cases of tuberculosis, announced that users of inhaled corticosteroids had a rate ratio of ~1.26 to 1.97 over never-users, with current and high-dose ICS users on the higher end of that range. Somehow, they also found that oral corticosteroids reduced the risk association, though OCS are strongly believed to increase risk for TB. The whole thing seems a bit suspect frankly. AJRCCM 2011;183:675-678.
Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.





